Manli Song
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 3
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 3
- Immunology top 10%
-
- Lanthanide and Transition Metal Complexes 2
-
- Cancer, Hypoxia, and Metabolism 2
-
- Radiopharmaceutical Chemistry and Applications 8
- Medical Imaging Techniques and Applications 3
- Monoclonal and Polyclonal Antibodies Research 2
-
- Peptidase Inhibition and Analysis 3
- Co-authors
- Xianzhong ZhangTing LiuXiaohong ChenChangrong ShiZhide GuoRongqiang ZhuangXinhui SuGaofei Hu
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Manli Song
13 papers receiving 885 citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Biomaterials 236
- Biomedical Engineering 576
- Immunology 218
- Materials Chemistry 303
- Cancer Research 98
Countries citing papers authored by Manli Song
This map shows the geographic impact of Manli Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manli Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manli Song more than expected).
Fields of papers citing papers by Manli Song
This network shows the impact of papers produced by Manli Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manli Song. The network helps show where Manli Song may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Manli Song, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2021 | 61 | |
| 3 | 2017 | 20 | |
| 4 | 2016 | 28 | |
| 5 | 2016 | 12 | |
| 6 | 2016 | 86 | |
| 7 | 2016 | 9 | |
| 8 | 2016 | 37 | |
| 9 | 2016 | 13 | |
| 10 | 2015 | 1 | |
| 11 | Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxiabreakdown → | 2015 | 585 |
| 12 | 2014 | 19 | |
| 13 | 2014 | 13 |
About Manli Song
Manli Song is a scholar working on Radiology, Nuclear Medicine and Imaging, Biomaterials and Cancer Research, having authored 13 papers that have together received 886 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (8 papers), Nanoparticle-Based Drug Delivery (3 papers), Medical Imaging Techniques and Applications (3 papers), Peptidase Inhibition and Analysis (3 papers), Nanoplatforms for cancer theranostics (3 papers), Lanthanide and Transition Metal Complexes (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Biomaterials (236 citations), Biomedical Engineering (576 citations) and Immunology (218 citations). Manli Song has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Xianzhong Zhang, Ting Liu, Xiaohong Chen, Changrong Shi, Zhide Guo, Rongqiang Zhuang, Xinhui Su, Gaofei Hu, Jiabin Cui and Nannan Li. Their work appears in journals such as Advanced Materials, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.